Fang Shou Guo, Shen Hongyuan, Wang Jibin, Tay Felicia P L, Liu Ding Xiang
Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.
Virology. 2008 Sep 30;379(2):175-80. doi: 10.1016/j.virol.2008.06.038. Epub 2008 Aug 3.
Coronavirus 3C-like proteinase (3CLpro) plays important roles in viral life cycle through extensive processing of the polyproteins 1a and 1ab into 12 mature, non-structural proteins (nsp5-nsp16). Structural and biochemical studies have revealed that all confirmed 3CLpro cleavage sites have a conserved Gln residue at the P1 position, which is thought to be absolutely required for efficient cleavage. Recent studies on murine hepatitis virus (MHV) showed that processing of the 1a polyprotein at the position between nsp10-nsp11 is essential for viral replication. In this report, we investigated the requirement of processing at the equivalent position for replication of avian coronavirus infectious bronchitis virus (IBV), using an infectious cloning system. The results showed that mutation of the P1 Gln to Pro or deletion of the Gln residue in the nsp10-nsp11/12 site completely abolished the 3CLpro-mediated processing, but allowed production of infectious recombinant viruses with variable degrees of growth defect, suggesting that cleavage at the nsp10-nsp11/12 site of IBV is dispensable for viral replication in cultured cells. This study would pave a way for potential vaccine development by generation of attenuated IBV from field isolates through manipulation of the nsp10-nsp11/12 cleavage site. Similar approaches would be also applicable to other human and animal coronaviruses.
冠状病毒3C样蛋白酶(3CLpro)通过将多聚蛋白1a和1ab广泛加工成12种成熟的非结构蛋白(nsp5 - nsp16),在病毒生命周期中发挥重要作用。结构和生化研究表明,所有已确认的3CLpro切割位点在P1位置都有一个保守的Gln残基,该残基被认为是有效切割绝对必需的。最近对鼠肝炎病毒(MHV)的研究表明,在nsp10 - nsp11之间的位置对1a多聚蛋白进行加工对于病毒复制至关重要。在本报告中,我们使用感染性克隆系统研究了禽冠状病毒传染性支气管炎病毒(IBV)复制时在等效位置进行加工的必要性。结果表明,将nsp10 - nsp11/12位点的P1 Gln突变为Pro或缺失Gln残基完全消除了3CLpro介导的加工,但允许产生具有不同程度生长缺陷的感染性重组病毒,这表明IBV在nsp10 - nsp11/12位点的切割对于培养细胞中的病毒复制是可有可无的。这项研究将为通过操纵nsp10 - nsp11/12切割位点从野外分离株产生减毒IBV来开发潜在疫苗铺平道路。类似的方法也适用于其他人类和动物冠状病毒。